web analytics

Scientific program

Breast cancer prevention/Genetics
Debate: That liberal use of genetic testing should be encouraged
Didactic: Management of gene mutations
Neoadjuvant therapy
Debate: That NAST choice should be based on TN stage vs biological subtype
Debate: That all patients with positive LN preNACT should have axillary dissection as part of cancer surgery
Didactic: Positioning of oral 5FU in adjuvant setting after PST
Adjuvant endocrine therapy
Debate: That OFS + AI should be standard of care in young patients with high-risk HR+ve breast cancer
Didactic: Duration of/choice of adjuvant endocrine therapy
Debate: That screening leads to over-treatment of women
Didactic: Screening technologies: USS v mammogram in different populations/role of MRI
Locoregional Tx
Didactic: What is the optimal way to achieve clear margins in BCS?
Debate: That regional nodal radiotherapy is required in all early stage node positive breast cancer
Debate: That axillary assessment should be routine for all patients with invasive breast cancer
Didactic: Biology of DCIS
Debate: That active surveillance for DCIS should be considered
Didactic: State of the art in Her2+ early breast cancer
Debate: That neratanib should be offer as a standard of care in adjuvant therapy of her2+ve breast cancer
PARP inhibitors: Where do they fit in breast cancer management?
That immunotherapy is likely to be a game-changer in breast cancer
Debate: That post-mastectomy radiotherapy after reconstruction is a good option
Debate: That fear and ignorance drive the rise in contralateral prophylactic mastectomy
Breast cancer 2022
How will breast cancer management change by 2022 for the:

  • Pathologist
  • Radiologist
  • Surgeon
  • Medical oncologist
  • Radiation oncologist